Tuesday, September 8, 2026

200 Successful Treatments: How Lu-177 PSMA Therapy is Revolutionizing Prostate Cancer Care in South Korea

The Catholic University Seoul St. Mary's Hospital's Urology Cancer Center achieves 200 cumulative treatments for metastatic prostate cancer.

LG Chem’s Legal Battle: How Foreign Tax Credit Limits Impact Global Operations

The Supreme Court ruled that losses from overseas operations can offset income in other countries for tax credit calculations.

[Video] Kim Ju Ae’s Solo Shot and Single Officer Salute… Will Conservative North Korean Society Accept a Female Successor?

Kim Ju-ae's potential succession faces challenges in North Korea's evolving landscape, impacting citizens' beliefs and expectations.

Tag: DLBCL

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

CS5001: 100% Complete Response Rate in DLBCL Clinical Trial – A Game Changer for Cancer Treatment?

LigaChem Biosciences reveals clinical data for cancer drug CS5001 targeting DLBCL, developed in partnership with CStone Pharmaceuticals.

CS5001 Breakthrough: 100% Complete Remission in DLBCL Trials – What This Means for Cancer Treatment

ABL Bio's ADC candidate shows complete response in all patients in early trials for first-line treatment of DLBCL.

Blood Test Alone May Predict Chemotherapy Response and Prognosis in Lymphoma Patients

South Korean researchers discover a mechanism reducing rituximab's effectiveness in DLBCL and propose a predictive blood biomarker.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.